Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Fulgent Genetics is based in the United States and engages in the sector 'Health & Social Work Services'. Find out more about Fulgent Genetics in our report focusing on the company's key figures ...

23andMe (NASDAQ:ME) $249.2 million At-home genetic testing providing personalized reports. Fulgent Genetics (NASDAQ:FLGT) $633.5 million Pediatric disease and oncology testing. Exact Sciences was ...

Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to earnings of $4.93 per share a year ago.

With factories in Cambodia, China and Vietnam, Fulgent Sun International manufactures sports and outdoor shoes for brands including Altra, Decathlon and Hoka. Founded in 1995, the company is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...